14 Mar 20234cites
BAAE-AgNPs Improve Symptoms of Diabetes in STZ-induced DiabeticRatsPublisher siteCurrent Pharmaceutical Biotechnology, Natural Antidiabetic Agents Studies
Active, last published 2026
In inflammasome and immune disorders
Naglaa A.
Gobba
Scholar“Research focused on Inflammasome and immune disorders and adjacent fields.”
Claim Your Profile10
H-index
447
Citations
Naglaa has not officially claimed their profile. If you are Naglaa, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
aglaa A. Gobba is a researcher working on Inflammasome and immune disorders. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Naglaa's work has been cited 447 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Inflammasome and immune disorders×3Natural Antidiabetic Agents Studies×3Drug-Induced Hepatotoxicity and Protection×3Inflammatory Bowel Disease×2Air Quality and Health Impacts×2
04 · Where I am
Affiliations
Affiliation on published researchMisr University for Science and Technology, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
1 workExpert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Naglaa?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you